These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 35931343)

  • 1. TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2022 Oct; 24(10):1051-1063. PubMed ID: 35931343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A4 and CYP3A5 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2023 Sep; 25(9):619-629. PubMed ID: 37419245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.
    Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; Turner AJ; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2024 Oct; 26(10):851-863. PubMed ID: 39032821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.
    Pratt VM; Cavallari LH; Del Tredici AL; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2021 Sep; 23(9):1047-1064. PubMed ID: 34118403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for Clinical Warfarin Genotyping Allele Selection: A Report of the Association for Molecular Pathology and the College of American Pathologists.
    Pratt VM; Cavallari LH; Del Tredici AL; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2020 Jul; 22(7):847-859. PubMed ID: 32380173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists.
    Pratt VM; Cavallari LH; Del Tredici AL; Hachad H; Ji Y; Moyer AM; Scott SA; Whirl-Carrillo M; Weck KE
    J Mol Diagn; 2019 Sep; 21(5):746-755. PubMed ID: 31075510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology.
    Pratt VM; Del Tredici AL; Hachad H; Ji Y; Kalman LV; Scott SA; Weck KE
    J Mol Diagn; 2018 May; 20(3):269-276. PubMed ID: 29474986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis.
    Lenz C; Narang A; Bousman CA
    Pharmacogenet Genomics; 2024 Jun; 34(4):130-134. PubMed ID: 38359167
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Goh LL; Lim CW; Leong KP; Ong KH
    Front Pharmacol; 2022; 13():837164. PubMed ID: 36210828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.
    Relling MV; Schwab M; Whirl-Carrillo M; Suarez-Kurtz G; Pui CH; Stein CM; Moyer AM; Evans WE; Klein TE; Antillon-Klussmann FG; Caudle KE; Kato M; Yeoh AEJ; Schmiegelow K; Yang JJ
    Clin Pharmacol Ther; 2019 May; 105(5):1095-1105. PubMed ID: 30447069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotyping NUDT15*3 rs1166855232 reveals higher frequency of potential adverse effects of thiopurines in Natives and Mestizos from Mexico.
    Texis T; Guzmán-Cruz C; Rodríguez-Dorantes M; Sánchez-García S; Mino-León D; Gonzalez-Covarrubias V
    Pharmacol Rep; 2022 Feb; 74(1):257-262. PubMed ID: 34091879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry.
    Schaeffeler E; Jaeger SU; Klumpp V; Yang JJ; Igel S; Hinze L; Stanulla M; Schwab M
    Genet Med; 2019 Sep; 21(9):2145-2150. PubMed ID: 30728528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Pharmacogenomics in the Efficacy and Safety of Thiopurines in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Gutiérrez-Valencia M; Leache L; Saiz LC; Beloqui JJ; Barajas M; Vicuña M; Erviti J
    J Clin Gastroenterol; 2023 Aug; 57(7):671-685. PubMed ID: 36322453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Reference Materials for TPMT and NUDT15: A GeT-RM Collaborative Project.
    Pratt VM; Wang WY; Boone EC; Broeckel U; Cody N; Edelmann L; Gaedigk A; Lynnes TC; Medeiros EB; Moyer AM; Mitchell MW; Scott SA; Starostik P; Turner A; Kalman LV
    J Mol Diagn; 2022 Oct; 24(10):1079-1088. PubMed ID: 35931342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogeomic implications of population diversity in Latin America: TPMT and NUDT15 polymorphisms and thiopurine dosing.
    Suarez-Kurtz G; Araújo GS; de Sousa SJ
    Pharmacogenet Genomics; 2020 Jan; 30(1):1-4. PubMed ID: 31651720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of thiopurines: distribution of TPMT and NUDT15 polymorphisms in the Brazilian Amazon.
    Ferreira GMA; Ribeiro Elias AB; Nascimento J; Monteiro WM; Melo GC; Baia-da-Silva DC; Lacerda MVG; Suarez-Kurtz G
    Pharmacogenet Genomics; 2020 Oct; 30(8):184-189. PubMed ID: 32453263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NUDT15: A bench to bedside success story.
    Moyer AM
    Clin Biochem; 2021 Jun; 92():1-8. PubMed ID: 33675810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive role of NUDT15 variants on thiopurine-induced myelotoxicity in Asian inflammatory bowel disease patients.
    Sutiman N; Chen S; Ling KL; Chuah SW; Leong WF; Nadiger V; Tjai M; Choon Kong CS; Schwender BJ; Chan W; Shim HH; Lim WC; Khor CC; Cheung YB; Chowbay B
    Pharmacogenomics; 2018 Jan; 19(1):31-43. PubMed ID: 29210335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results.
    Dickson AL; Daniel LL; Zanussi J; Dale Plummer W; Wei WQ; Liu G; Reese T; Anandi P; Birdwell KA; Kawai V; Cox NJ; Dupont WD; Hung AM; Feng Q; Stein CM; Chung CP
    Clin Pharmacol Ther; 2022 Jan; 111(1):263-271. PubMed ID: 34582038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.